By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Amgen

Amgen’s Otezla launched for paediatric plaque psoriasis in US Pharmaceutical Technology11:10Pharma Biotech

Eye on pharma: Celltrion, Costco partnership; Amgen sues Samsung Bioepis; denosumab results Center for Biosimilars12:23Celltrion FDA Patent Law

Apremilast now available in US for pediatric plaque psoriasis American Journal of Managed Care20:13FDA Pharma Biotech

Biosimilar updates: Celltrion, Costco partnership; Amgen sues Samsung Bioepis; denosumab results American Journal of Managed Care15:31Celltrion Pharma Top Tech Brands

First severe plaque psoriasis oral therapy for ages 6-17 available in the US Outsourcing-Pharma.com11:13FDA Pharma Biotech

Amgen files bpcia lawsuit against Samsung Bioepis prolia® / xgeva® proposed biosimilar SB16 JD Supra19:46New Jersey Business Consumer Electronics Pharma

Amgen Inc. (NASDAQ:AMGN) delivered a better roe than its industry Simply Wall St20:52Stock Markets (World) Stock Market Pharma

Fifth eylea® biosimilar FDA-approved: Amgen’s pavblu™ (aflibercept-ayyh) JD Supra16:00FDA West Virginia Business North Dakota Business

Organisers of Amgen Irish Open 2024 advise fans to tee off tournament with public transport Northern Ireland Travel News16:19Public Transport Pharma Biotech

Epitope claims live on at the European patent office JD Supra20:52Sanofi Pharma SCOTUS

Latest News

In the last 7 days

Amgen Stock Rises Almost 20% in 6 Months: Buy, Sell or Hold? Zacks15:34 5-Sept-24

Amgen Inc. (NASDAQ:AMGN) Delivered A Better ROE Than Its Industry Simply Wall St20:52 4-Sept-24

In the last month

Amgen To Present At The 2024 Wells Fargo Healthcare Conference PR Newswire (Press Release)21:00 30-Aug-24

Epitope Claims Live On at the European Patent Office JD Supra20:52 30-Aug-24

Amgen To Present At The Morgan Stanley 22ND Annual Global Healthcare Conference Amgen (Press Release)21:03 29-Aug-24

Fifth EYLEA® Biosimilar FDA-Approved: Amgen’s Pavblu™ (aflibercept-ayyh) JD Supra16:00 29-Aug-24

Intuit, Amgen And Sprott Uranium Miners ETF: CNBC's 'Final Trades' Benzinga13:56 29-Aug-24

Newcastle looks blooming great for start of Irish Open The Down Recorder10:26 29-Aug-24

Organisers of Amgen Irish Open 2024 Advise Fans to Tee Off Tournament with Public Transport Northern Ireland Travel News16:19 26-Aug-24

Biosimilar Updates: Celltrion, Costco Partnership; Amgen Sues Samsung Bioepis; Denosumab Results American Journal of Managed Care15:31 25-Aug-24

First severe plaque psoriasis oral therapy for ages 6-17 available in the US Outsourcing-Pharma.com11:13 22-Aug-24

BioMarin revamps leadership with ex-Roche, Amgen execs pharmaphorum08:17 22-Aug-24

Interesting AMGN Put And Call Options For November 15th Nasdaq17:04 21-Aug-24

Eye on Pharma: Celltrion, Costco Partnership; Amgen Sues Samsung Bioepis; Denosumab Results Center for Biosimilars12:23 21-Aug-24

Amgen’s Otezla launched for paediatric plaque psoriasis in US Pharmaceutical Technology11:10 21-Aug-24

Apremilast Now Available in US for Pediatric Plaque Psoriasis American Journal of Managed Care20:13 20-Aug-24

Amgen Files BPCIA Lawsuit Against Samsung Bioepis Prolia® / Xgeva® Proposed Biosimilar SB16 JD Supra19:46 20-Aug-24

Otezla® (Apremilast) Now Available In The U.S. For Moderate To Severe Pediatric Plaque Psoriasis PR Newswire (Press Release)14:02 20-Aug-24

This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in… The Motley Fool11:23 17-Aug-24

The PTAB Axes Skin Treatment Patent Under Amgen JD Supra18:14 15-Aug-24

Amgen Files BPCIA Complaint Against Samsung Bioepsis Regarding Denosumab JD Supra17:55 14-Aug-24

Amgen Sues Samsung Biologics to Block Prolia, XGEVA Biosimilars Bloomberg Law21:52 13-Aug-24

Amgen Plans to Open New Technology and Innovation Site in India Genetic Engineering and Biotechnology News14:48 12-Aug-24

Amgen set to open new tech centre in Hyderabad by end of year The Times of India03:46 10-Aug-24

Biotech giant Amgen announces new office in tech-savvy Hyderabad Investment Monitor16:55 9-Aug-24

American BioTech firm Amgen to open new site in Hyderabad; CM Revanth calls Telangana, 'The future state' Deccan Herald14:19 9-Aug-24

Amgen to open new tech and innovation centre in Hyderabad by 2024-end The Times of India13:58 9-Aug-24

American biopharmaceutical giant Amgen to open its India office in Hyderabad The Hindu11:43 9-Aug-24

Amgen to open new tech and innovation center in Hyderabad by end of 2024 The Times of India10:00 9-Aug-24

Biotech giant Amgen plans to open to technology & innovation centre in Hyderabad The Economic Times09:45 9-Aug-24

Amgen is Launching Biotechnology and AI Hub in Hyderabad Analytics India Magazine07:39 9-Aug-24

view more headlines

5 Sept 15:34

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.